scholarly journals Long-term data of the new transcutaneous partially implantable bone conduction hearing system Osia®

Author(s):  
Ann-Kathrin Rauch ◽  
Thomas Wesarg ◽  
Antje Aschendorff ◽  
Iva Speck ◽  
Susan Arndt

Abstract Purpose The new active transcutaneous partially implantable osseointegrated system Cochlear™ Osia® System is indicated in case of conductive or mixed hearing loss (CHL/MHL) with a maximum average bone conduction hearing loss of 55 dB, or in single-sided deafness (SSD). The implant directly stimulates the bone via a piezoelectric transducer and is directed by an external sound processor. We conducted a monocentric retrospective longitudinal within-subject clinical study at our tertiary academic referral center. The aim was to investigate long-term data (2017–2021) on audiological outcomes and hearing-related quality of life for the Osia system. Methods Between 2017 and 2020, 22 adults (18: CHL/MHL; 3: SSD) were implanted with the Osia100 implant; seven received bilateral implants. As of 10/2020, the sound processor was upgraded to Osia 2. Results Mean Osia system use by 04/2021 was 30.9 ± 8.6 months (range 17–40 months). Unaided bone conduction thresholds were unchanged postoperatively. One patient had to be explanted because of prolonged wound infection. Aided hearing thresholds were significantly lower compared to the unaided thresholds preoperatively, along with a marked increase in speech recognition in quiet. Speech processor upgrade resulted in a stable benefit. Patients with CHL/MHL and SSD showed a similar improvement in self-rated hearing performance revealed by SSQ, APHAB, and HUI questionnaires. Conclusion The Osia system is a safe, effective and sustainable option for treatment of conductive and mixed hearing loss or single-sided deafness.

2021 ◽  
Vol 75 (4) ◽  
pp. 1-5
Author(s):  
Joanna Marszał ◽  
Renata Gibasiewicz ◽  
Magdalena Błaszczyk ◽  
Maria Gawlowska ◽  
Wojciech Gawęcki

Introduction: Nowadays, there are many options to treat hearing-impaired patients: tympanoplastic surgery, hearing aids and a wide range of implantable devices. Objective: The aim of this study is to present the mid-term audiological and quality of life benefits after the implantation of the Osia®, a new active piezoelectric bone conduction hearing implant. Material and methods: The state of the tissues in implanted area, as well as audiological and quality of life results were analyzed six, nine and twelve months after implantation in a group of four adult patients with bilateral mixed hearing loss. Results: In all the cases, no postoperative complications were found. One year after surgery the mean audiological gain in FF PTA4 (pure tone average for 0.5, 1, 2, and 4 kHz) was 52.2±3.5 dB in comparison to the unaided situation, the mean speech understanding with Osia® in quiet was 90±8.2% for 50dB SPL, 98.8±2.5% for 65dB SPL and 100±0% for 80dB SPL, and mean speech understanding with Osia® in noise was 37.5%±23.6 for 50dB SPL, 93.8±4.8% for 65dB SPL and 98.8±2.5% for 80dB SPL. There was also an evident improvement in the quality of hearing as well as in the quality of life, measured by the APHAB (Abbreviated Profile of Hearing Aid Benefit) and the SSQ (Speech, Spatial and Qualities of Hearing Scale). Conclusions: The Osia® is an effective treatment option for patients with bilateral mixed hearing loss. The mid-term audiological and quality of life results are excellent, but further observations including bigger groups of patients and a longer follow-up are required.


2014 ◽  
Vol 35 (6) ◽  
pp. 1017-1025 ◽  
Author(s):  
Jolien Desmet ◽  
Kristien Wouters ◽  
Marc De Bodt ◽  
Paul Van de Heyning

2015 ◽  
Vol 20 (01) ◽  
pp. 034-038 ◽  
Author(s):  
Maria Mondelli ◽  
Thais Mariano ◽  
Heitor Honório ◽  
Rubens Brito

Introduction Hearing loss is the most common clinical finding in patients with malformation of the external ear canal. Among the possibilities of treatment, there is the adaptation of hearing aids by bone conduction and the adaptation of implantable hearing aids. Objective To assess speech perception with the use of Vibrant Soundbridge (VBS - MED-EL, Innsbruck, Austria) associated with additional amplification in patients with bilateral craniofacial malformation. Method We evaluated 11 patients with bilateral malformation over 12 years with mixed hearing loss or bilateral conductive. They were using the Softband (Oticon Medical, Sweden) and bone conduction hearing aid in the ear opposite the one with the VSB. We performed the evaluation of speech perception using the Hearing in Noise Test. Results Participants were eight men and three women with a mean of 19.5 years. The signal / noise ratio presented significant results in patients fitted with VSB and bone conduction hearing aid. Conclusion The results of speech perception were significantly better with use of VBS combined with bone conduction hearing aids.


1992 ◽  
Vol 106 (1) ◽  
pp. 68-74 ◽  
Author(s):  
Phillip S. Wade ◽  
Jerry J. Halik ◽  
Marshall Chasin

Clinical experience with transcutaneous bone conduction implants has demonstrated that they are most beneficial for patients with purely conductive hearing loss in at least one ear. Percutaneous bone conduction implants, however, have been reported to provide adequate benefit for patients with mixed hearing loss with bone conduction pure-tone averages up to 45 db hl (Tjellstrom, 1989). The results of 24 Xomed Audiant osseointegrated bone conduction hearing devices (including a clinical trial on two patients using a new, larger magnet [Neodynium Iron Boron]), plus the results of eleven patients implanted and fitted with the percutaneous bone-anchored hearing aid are reported. Aided results with these devices will be presented. In addition, general comparisons of benefit obtained with the two devices will be made for patients who exhibit similar hearing losses. Finally, a direct comparison will be made on two patients who have undergone both implant procedures.


2013 ◽  
Vol 133 (10) ◽  
pp. 1058-1064 ◽  
Author(s):  
Maurizio Barbara ◽  
Marco Perotti ◽  
Barbara Gioia ◽  
Luigi Volpini ◽  
Simonetta Monini

Author(s):  
Domenico Cuda ◽  
Alessandra Murri ◽  
Paolo Mochi ◽  
Anna Mainardi

Abstract Introduction Bone anchored hearing solutions are a well-known option for patients with a conductive, mixed conductive-sensorineural hearing loss and those with single-sided deafness. Objective The aim of the present study was to evaluate the Ponto bone-anchored hearing system in terms of behavioral performance and self-reported outcomes, by comparing unaided and aided performance (softband and abutment), as well as aided performance with the sound processor on softband (preoperatively) versus abutment (postoperatively). Methods Fourteen adult bone-anchored candidates, with either a bilateral (n = 12) or unilateral (n = 2) conductive or mixed hearing loss, participated in the present study. Sound-field hearing thresholds were evaluated unaided and aided (softband and abutment). A speech-in-noise test was also performed unaided and aided for two spatial configurations (S0N90; implanted side; S0N90; nonimplanted side). The Glasgow Health Status Inventory and the Speech, Spatial and Quality of sound questionnaires were administered pre- and postsurgery to compare quality of life and perceived unaided and aided performance. Skin reaction (Holgers scores) was evaluated at 15 days, 6 weeks, and 10 weeks after surgery. Results Significant improvements postoperatively relative to unaided were obtained for sound-field thresholds at all tested frequencies. Additionally, sound-field thresholds were significantly improved with the sound processor on abutment relative to the softband at frequencies > 1 kHz. Improved performance postoperatively relative to unaided was also obtained in the speech-in-noise test and in self-reported outcomes. Conclusions Improvements in behavioral performance and self-reported outcomes were obtained with the sound processor mounted on abutment.


2021 ◽  
Vol 70 (2) ◽  
pp. 102-108
Author(s):  
Lukáš Varga ◽  
Branislava Bercíková ◽  
Zuzana Kabátová ◽  
Milan Profant

ntroduction: Bone conduction implants are currently used for rehabilitation of conductive and mixed hearing loss as well as for single sided deafness. A growing number of these implants available on the market increases requirements on detailed knowledge on their technical properties, and on their advantages and disadvantages in clinical practice. Sophono is one of the recent members in this implant group. The aim of the study is to summarize our first experiences with Sophono at our implantation center in Bratislava. Patients and methods: We present data of the first two adult patients who underwent Sophono implantation. Both suffered from bilateral conductive hearing loss of different etiology. We focused on their audiological functional outcomes, basic surgical aspects and subjective assessment by the patients. Results: In free field tone audiometry with the implant, both patients achieved improvement of hearing thresholds by 21.25 dB and 31.25 dB, respectively. In speech tests with and without noise, we also demonstrated a clear benefit of the implant, which was in a narrow relationship with the degrees of their hearing loss: speech discrimination scores in noise were 30% and 60% in patients 1 and 2, respectively. The surgical procedure in Sophono implantation is relatively simple and does not include any work on middle ear structures. Patient satisfaction with the implant does not always correspond to the measured functional outcomes. Conclusion: The Sophono implant represents a suitable option for rehabilitation of conductive and mixed hearing loss as well as single sided deafness in selected patients. The candidate selection is always based on comprehensive assessment in which the audiological results are an elementary criterion, but definitely not a single one. Keywords: Sophono – implantation – conductive hearing loss


Sign in / Sign up

Export Citation Format

Share Document